Baidu
map

陈忠教授:血管外科医师既要“左手一把刀”,还要“右手一根管”MedSci专访CEC2012:

2012-11-05 MedSci MedSci原创

  由上海复旦大学附属中山医院、首都医科大学附属北京安贞医院和中国人民解放军总医院(301医院)三家血管外科中心联合主办的“中国血管论坛暨2012年国家继续教育学习班”(简称CEC(China Endovascular Course)2012)于11月1日--4日在上海国际会议中心举行。11月2日MedSci通讯员有幸采访了大会共同主席、北京安贞医院血管外科陈忠教授。   MedSci通讯员:汪

  由上海复旦大学附属中山医院、首都医科大学附属北京安贞医院和中国人民解放军总医院(301医院)三家血管外科中心联合主办的“中国血管论坛暨2012年国家继续教育学习班”(简称CEC(China Endovascular Course)2012)于11月1日--4日在上海国际会议中心举行。11月2日MedSci通讯员有幸采访了大会共同主席、北京安贞医院血管外科陈忠教授。

  MedSci通讯员:汪忠镐院士是我国血管外科领域的奠基人,也是您的恩师,请问汪院士给您留下了怎样的深刻印象?他给您的最大影响有哪些?您能简单谈一下么?

  陈忠教授:汪忠镐院士是我国血管外科领域的奠基人之一,也是我的入门老师,他不仅是国内着名的血管外科专家,在国际上也享负盛名。1984年至1993年的九年间,我有幸师从汪忠镐院士,这九年也是我从一个年轻医师逐渐成长起来的关键几年,从基本的外科训练到血管外科的诊疗,再到血管外科腔内治疗的关键技术,我都受到了汪忠镐院士的言传身教,汪忠镐院士对患者的认真负责和对学术的追求都令我受益匪浅,包括整个北京安贞医院的血管外科团队也受到了汪忠镐院士的谆谆教导,使得安贞医院的血管外科成为国内较早的专业独立的血管外科科室。谈到汪忠镐院士,我就想到了另一位我国心血管外科的前辈,也是安贞医院的老院长吴英恺院士,他在1984年组建北京安贞医院时就成立了血管科,这是一个非常有远见的做法。在如今的血管外科领域,除了传统手术治疗之外,随着腔内技术的兴起,诊疗手段开始了微创化革新,同时药物治疗也是不可缺少的一种治疗手段。

  MedSci通讯员:正如您所言,医学界经验与技术的传承与创新十分重要,您对年轻的血管外科医师如何开展高水平的临床研究有何建议?

  陈忠教授:自我从2003年成为北京安贞医院血管外科的负责人以来,十年间血管外科领域发生了巨大的变化,取得了飞速的发展,从传统手术治疗走入了一个腔内血管治疗的时代,现在几乎80%的血管外科疾病都采用腔内治疗,所以对如今的血管外科医师而言,除了要掌握传统手术技能,还要掌握腔内治疗的各种技术和技巧,必须要有一个“两手抓,两手都要硬”的理念,只拿“左手一把刀”不够,还要“右手一根管”。

  随着国人生活水平的不断提高,血管疾病的发病率在我国正以惊人的速度增长。随着诊疗方法和治疗技术的不断创新与发展,血管外科专业人才需求将更甚,这就对如今的血管外科医师提出了更高的要求,为此CEC大会也提供了一个专业继续教育平台,帮助广大年轻血管外科医师学习最近的临床研究成果和掌握先进的技术,这需要多家医院和中心共同合作,密切配合,相信通过大家的共同努力,我国血管外科医师的诊疗水平不断提高,开展更多高水平的临床研究。

  MedSci通讯员:我们了解到明年的CEC大会将由北京安贞医院主办,请问您展望一下明年的大会?

  陈忠教授:CEC大会自2008年开始举办,到今年已经是第五个年头了,五年间大会的质量不断提高,大会规模也日益扩大,我期待明年的大会能够在今年的基础上能有进一步的提高,希望不只是大会规模继续扩大,在参会嘉宾,国际会议合作和手术演示等方面也希望大会能有进一步的提高。

  关于陈忠教授:

  北京安贞医院血管外科主任

  擅长:胸、腹主动脉瘤、颈动脉瘤、颈动脉体瘤及各种周围动脉瘤的手术及介入治疗;各种类型大动脉炎特别是头臂型及肾型大动脉炎的介入和手术治疗;布—加氏综合征的介入和手术治疗等;各种动脉硬化闭塞症的介入和手术治疗。

  成果发表:在国家一类杂志发表专业学术论文70余篇,SCI文章6篇,获省市级科研成果奖4项,作为编委参与编写《实用血管外科学》、《血管外科手术并发症的预防与 处理》;作为副主编参与编写《心胸血管外科临床常见疑难问题及对策》、《周围血管腔内技术》等四部专着,作为主译参与译着《周围血管疾病诊断与治疗》

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
    2012-11-09 ppswppp

    挺好。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
    2012-11-06 liye789132257
  6. [GetPortalCommentsPageByObjectIdResponse(id=1703147, encodeId=25711e031478f, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Sep 23 22:00:00 CST 2013, time=2013-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4921, encodeId=d0234921f7, content=挺好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ppswppp, createdTime=Fri Nov 09 13:50:00 CST 2012, time=2012-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423421, encodeId=fad71423421fc, content=<a href='/topic/show?id=0deb8961144' target=_blank style='color:#2F92EE;'>#血管外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89611, encryptionId=0deb8961144, topicName=血管外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e5c3789547, createdName=bbjsj_1980, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522825, encodeId=483415228259a, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587573, encodeId=426e158e573fb, content=<a href='/topic/show?id=453d444478' target=_blank style='color:#2F92EE;'>#CEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4444, encryptionId=453d444478, topicName=CEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfc17510252, createdName=liye789132257, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605840, encodeId=4226160584045, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Nov 06 15:00:00 CST 2012, time=2012-11-06, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map